,78,83,84 In addition, KEAP1 mutations would drive KRAS G12Ci resistance via NRF2-mediated glutaminolysis and oxidative stress buffering in KRAS-driven NSCLC.82 Here, NFE2L2 is linked to non-small cell lung carcinoma.